Health Catalyst, Inc.
HCAT- Exchange
- Nasdaq
- Industry
- Services-Computer Programming, Data Processing, Etc.
- SEC CIK
- 0001636422
In the last 90 days, Health Catalyst, Inc. insiders filed 1 open-market purchase and 0 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $104.0M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:55 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $178.0M (57.2% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Feb 22, 2024 | Jan 9, 2023 | Mar 1, 2022 |
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M |
| Operating expenses | $312.5M | $210.6M | $258.7M | $273.2M | $261.2M |
| Research and development | $49.8M | $58.0M | $72.6M | $75.7M | $62.7M |
| Selling, general and administrative | $49.6M | $56.8M | $76.6M | $61.7M | $85.9M |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M |
| Income tax | $716.0K | $333.0K | $356.0K | -$4.28M | -$6.90M |
| Net income | -$178.0M | -$69.5M | -$118.1M | -$137.4M | -$153.2M |
| EPS, basic | $-2.55 | $-1.15 | $-2.09 | $-2.56 | $-3.23 |
| EPS, diluted | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 |
| Weighted shares, basic | 69.9M | 60.2M | 56.4M | 53.7M | 47.5M |
| Weighted shares, diluted | 69.9M | 60.2M | 56.4M | 54.1M | 47.5M |
| Margins and growth | |||||
| Operating margin | -51.7% | -22.8% | -42.9% | -50.7% | -59.4% |
| Net margin | -57.2% | -22.7% | -39.9% | -49.7% | -63.3% |
| Revenue growth, year over year | +1.5% | +3.6% | +7.1% | +14.2% | +28.1% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Feb 22, 2024 | Jan 9, 2023 | Mar 1, 2022 |
| Cash and equivalents | $50.8M | $249.6M | $106.3M | $116.3M | $193.2M |
| Short-term investments | $44.9M | $142.4M | $211.5M | $247.2M | $251.8M |
| Accounts receivable | $59.1M | $57.2M | $60.3M | $48.0M | $48.8M |
| Total current assets | $169.3M | $465.6M | $393.4M | $427.8M | $508.4M |
| Property, plant and equipment | $33.8M | $29.4M | $25.7M | $25.9M | $23.3M |
| Goodwill | $209.1M | $259.8M | $190.7M | $186.0M | $170.0M |
| Intangible assets | $77.7M | $86.1M | $73.4M | $92.2M | $104.8M |
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M |
| Accounts payable | $9.36M | $11.4M | $6.64M | $4.42M | $4.69M |
| Short-term debt | $1.63M | $231.2M | – | – | – |
| Total current liabilities | $89.6M | $325.9M | $89.0M | $82.5M | $93.1M |
| Long-term debt | $151.6M | $151.2M | $228.0M | $226.5M | $180.9M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M |
| Shareholders' equity | $245.8M | $365.2M | $366.9M | $425.0M | $522.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 26, 2025 | Feb 22, 2024 | Jan 9, 2023 | Mar 1, 2022 |
| Operating cash flow | $731.0K | $14.6M | -$33.1M | -$35.3M | -$23.1M |
| Capital expenditures | $968.0K | $1.62M | $1.24M | $2.17M | $10.4M |
| Free cash flow | -$237.0K | $12.9M | -$34.3M | -$37.4M | -$33.6M |
| Depreciation and amortization | $50.5M | $41.4M | $42.2M | $48.3M | $37.5M |
| Stock-based compensation | $27.0M | $40.1M | $55.8M | $72.1M | $65.1M |
| Share buybacks | $5.00M | $0 | $1.81M | $8.39M | – |
| Investing cash flow | $36.2M | -$22.9M | $20.3M | -$39.0M | -$139.7M |
| Financing cash flow | -$235.8M | $151.7M | $2.73M | -$2.61M | $264.1M |
| Net change in cash | -$198.8M | $143.4M | -$10.0M | -$76.9M | $101.3M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 8.7% | 13.1% | 18.8% | 26.1% | 26.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 76.2M | +7.7% | SEC |
| Jul 31, 2026 | 75.3M | +6.9% | SEC |
| May 8, 2026 | 73.9M | +6.2% | SEC |
| Mar 5, 2026 | 73.6M | +4.8% | SEC |
| Dec 31, 2025 | 73.6M | +4.8% | SEC |
| Oct 23, 2025 | 70.7M | +16.2% | SEC |
| Jul 31, 2025 | 70.4M | +16.4% | SEC |
| May 5, 2025 | 69.6M | +17.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.